Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Silvana Wilken"'
Autor:
Kamal H. Hussein, Boyukkhanim Ahmadzada, Julio Cisneros Correa, Ahmer Sultan, Silvana Wilken, Bruce Amiot, Scott L. Nyberg
Publikováno v:
Bioactive Materials, Vol 40, Iss , Pp 280-305 (2024)
Liver transplantation represents the only definitive treatment for patients with end-stage liver disease. However, the shortage of liver donors provokes a dramatic gap between available grafts and patients on the waiting list. Whole liver bioengineer
Externí odkaz:
https://doaj.org/article/8316c7a59f674a33ae4f6b296f6524aa
Autor:
Peter Tang, Eriselda Keshi, Silvana Wilken, Louise Wutsdorff, Julienne Mougnekabol, Johann Pratschke, Igor M. Sauer, Nils Haep
Publikováno v:
Stem Cell Research, Vol 80, Iss , Pp 103516- (2024)
Metabolic dysfunction-associated fatty liver disease (MAFLD), the leading cause of end-stage liver disease in developed countries, is expected to increase over the next decade. Characterized by hepatic steatosis, MAFLD is commonly studied in animal m
Externí odkaz:
https://doaj.org/article/bfcc31c69183491daa51b0deb0de3767
Autor:
Philipp Felgendreff, Seyed M. Hosseiniasl, Lisa Felgendreff, Bruce P. Amiot, Anna Minshew, Boyukkhanim Ahmadzada, Zhi Qu, Silvana Wilken, Ines Arribas Gomez, Scott L. Nyberg, Casey N. Cook
Publikováno v:
Frontiers in Medicine, Vol 11 (2024)
IntroductionAcute liver failure (ALF) is defined as acute loss of liver function leading to hepatic encephalopathy associated with a high risk of patient death. Brain injury markers in serum and tissue can help detect and monitor ALF-associated brain
Externí odkaz:
https://doaj.org/article/1d756a9fcf594791b825362a564dc6d2
Autor:
Philipp Felgendreff, Seyed Mohammad Hosseiniasl, Anna Minshew, Bruce P. Amiot, Silvana Wilken, Boyukkhanim Ahmadzada, Robert C. Huebert, Nidhi Jalan Sakrikar, Noah G. Engles, Peggy Halsten, Kendra Mariakis, John Barry, Shawn Riesgraf, Chris Fecteau, Jeffrey J. Ross, Scott L. Nyberg
Publikováno v:
Biomedicines, Vol 12, Iss 6, p 1272 (2024)
In this study, a mixed porcine–human bioengineered liver (MPH-BEL) was used in a preclinical setup of extracorporeal liver support devices as a treatment for a model of post-resection liver failure (PRLF). The potential for human clinical applicati
Externí odkaz:
https://doaj.org/article/09ed58633aeb4bbf931d90a7f38ea04d